We are live on ! Find out more
LAB icon

Standard BioTools
LAB

99 hedge funds and large institutions have $422M invested in Standard BioTools in 2018 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 39 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,594% more call options, than puts

Call options by funds: $288K | Put options by funds: $17K

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

182% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 11

117% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 18

45% more capital invested

Capital invested by funds: $291M → $422M (+$131M)

25% more funds holding

Funds holding: 79 → 99 (+20)

2.26% more ownership

Funds ownership: 99.23% → 101.5% (+2.3%)

Holders
99
Holders Change
+20
Holders Change %
+25.32%
% of All Funds
2.21%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
31
Increased
39
Reduced
18
Closed
11
Calls
$288K
Puts
$17K
Net Calls
+$271K
Net Calls Change
-$95K

Top Buyers

1
DCM
Driehaus Capital Management
Illinois
+$18M
2
Neuberger Berman Group
Neuberger Berman Group
New York
+$7.24M
3
Russell Investments Group
Russell Investments Group
United Kingdom
+$6.93M
4
RI
RTW Investments
New York
+$6.89M
5
Primecap Management
Primecap Management
California
+$6.35M

Top Sellers

1
O
OrbiMed
New York
-$8.07M
2
LCS
Levin Capital Strategies
New York
-$4.94M
3
ECM
Endurant Capital Management
California
-$2.54M
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$717K
5
Barclays
Barclays
United Kingdom
-$394K
Name Holding Trade Value Shares
Change 		Change in
Stake
CPC
51
Cookson Peirce & Co
Pennsylvania
$536K +$484K +62,150 New
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$494K +$292K +37,500 +189%
TA
53
Teachers Advisors
New York
$486K – – –
AG
54
Algert Global
California
$483K +$436K +56,019 New
EGM
55
Engineers Gate Manager
New York
$470K +$185K +23,761 +77%
California Public Employees Retirement System
56
California Public Employees Retirement System
California
$469K – – –
AllianceBernstein
57
AllianceBernstein
Tennessee
$453K +$35.1K +4,500 +9%
Citadel Advisors
58
Citadel Advisors
Florida
$435K +$138K +17,721 +54%
EP
59
Eversept Partners
New York
$435K +$393K +50,455 New
Tudor Investment Corp
60
Tudor Investment Corp
Connecticut
$417K +$377K +48,415 New
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$346K – – –
MIM
62
Monashee Investment Management
Massachusetts
$345K +$312K +40,000 New
Goldman Sachs
63
Goldman Sachs
New York
$338K -$143K -18,384 -32%
MPAM
64
Monarch Partners Asset Management
Massachusetts
$317K +$287K +36,798 New
CEP
65
Chicago Equity Partners
Illinois
$313K +$283K +36,300 New
PP
66
PDT Partners
New York
$299K +$135K +17,350 +100%
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$297K +$80.7K +10,358 +43%
Nisa Investment Advisors
68
Nisa Investment Advisors
Missouri
$272K – – –
TA
69
Tiedemann Advisors
New York
$247K +$224K +28,703 New
PPA
70
Parametric Portfolio Associates
Washington
$237K -$41.7K -5,355 -16%
State Board of Administration of Florida Retirement System
71
State Board of Administration of Florida Retirement System
Florida
$236K – – –
Wells Fargo
72
Wells Fargo
California
$229K -$182K -23,343 -47%
CSS
73
Cubist Systematic Strategies
Connecticut
$224K +$202K +25,963 New
AQR Capital Management
74
AQR Capital Management
Connecticut
$216K +$196K +25,111 New
SEI Investments
75
SEI Investments
Pennsylvania
$175K +$32.7K +4,199 +26%
1 2
3
4 5

LAB Hedge Fund Activity: Q4 2018 in Review

99 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2018, worth a combined $422M — up 45% from $291M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new LAB positions and 11 closed out — a net gain of 20 holders — while 39 added to existing stakes and 18 trimmed.

The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $18M. The largest seller was OrbiMed, exiting entirely with an estimated $8.07M sold.

  • 99 institutional investors held Standard BioTools (LAB) as of Q4 2018, up from 79 in Q3 2018.
  • Funds reported $422M of Standard BioTools stock for Q4 2018, up 45% quarter-over-quarter.
  • 31 funds opened new Standard BioTools positions in Q4 2018 and 11 closed out, a net change of +20 holders.
  • The largest Standard BioTools buyer in Q4 2018 was Driehaus Capital Management, an estimated $18M added.
  • The largest Standard BioTools seller in Q4 2018 was OrbiMed, an estimated $8.07M sold.

Based on aggregated 13F filings for Q4 2018.